Virus-Inspired Membrane Encapsulation of DNA Nanostructures To Achieve In Vivo Stability
Source abstract
Abstract
DNA nanotechnology enables engineering of molecular-scale devices with exquisite control over geometry and site-specific functionalization. This capability promises compelling advantages in advancing nanomedicine; nevertheless, instability in biological environments and innate immune activation remain as obstacles for in vivo application. Natural particle systems (i.e., viruses) have evolved mechanisms to maintain structural integrity and avoid immune recognition during infection, including encapsulation of their genome and protein capsid shell in a lipid envelope. Here we introduce virus-inspired enveloped DNA nanostructures as a design strategy for biomedical applications. Achieving a high yield of tightly wrapped unilamellar nanostructures, mimicking the morphology of enveloped virus particles, required precise control over the density of attached lipid conjugates and was achieved at 1 per ∼180 nm(2). Envelopment of DNA nanostructures in PEGylated lipid bilayers conferred protection against nuclease digestion. Immune activation was decreased 2 orders of magnitude below controls, and pharmacokinetic bioavailability improved by a factor of 17. By establishing a design strategy suitable for biomedical applications, we have provided a platform for the engineering of sophisticated, translation-ready DNA nanodevices.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Bacteriophages and microbial interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, United States
Funding
U.S. Department of Defense · National Institutes of Health · National Science Foundation
References (38)
Show source-provided references
1. Glauert A. M. · Nature · 1962 · 196 · 95310.1038/196953a0 ↗
2. Horne R. W. · Nature · 1963 · 200 · 134010.1038/2001340a0 ↗
3. Douglas S. M. · Science · 2012 · 335 · 83110.1126/science.1214081 ↗
4. Klibanov A. L. · FEBS Lett. · 1990 · 268 · 23510.1016/0014-5793(90)81016-H ↗
5. Perrault S. D. · Nano Lett. · 2009 · 9 · 190910.1021/nl900031y ↗
6. Rodriguez P. L. · Science · 2013 · 339 · 97110.1126/science.1229568 ↗
7. Åkerman M. E. · Proc. Natl. Acad. Sci. U.S.A. · 2002 · 99 · 1261710.1073/pnas.152463399 ↗
8. Farokhzad O. · Cancer Res. · 2004 · 64 · 766810.1158/0008-5472.CAN-04-2550 ↗
9. Perrault S. D. · Proc. Natl. Acad. Sci. U.S.A. · 2010 · 107 · 1119410.1073/pnas.1001367107 ↗
10. Park J.-H. · Proc. Natl. Acad. Sci. U.S.A. · 2010 · 107 · 98110.1073/pnas.0909565107 ↗
11. Von Maltzahn G. · Nat. Mater. · 2011 · 10 · 54510.1038/nmat3049 ↗
12. Seeman N. C. · Annu. Rev. Biochem. · 2010 · 79 · 6510.1146/annurev-biochem-060308-102244 ↗
13. Rothemund P. W. K. · Nature · 2006 · 440 · 29710.1038/nature04586 ↗
14. Douglas S. M. · Nature · 2009 · 459 · 41410.1038/nature08016 ↗
15. Dietz H. · Science · 2009 · 325 · 72510.1126/science.1174251 ↗
16. Ke Y. · Science · 2012 · 338 · 117710.1126/science.1227268 ↗
17. Schüller V. J. · ACS Nano · 2011 · 5 · 969610.1021/nn203161y ↗
18. Li J. · ACS Nano · 2011 · 5 · 878310.1021/nn202774x ↗
19. Langecker M. · Science · 2012 · 338 · 93210.1126/science.1225624 ↗
20. Rudchenko M. · Nat. Nanotechnol. · 2013 · 8 · 58010.1038/nnano.2013.142 ↗
21. Nadano D. · Clin. Chem. · 1993 · 39 · 44810.1093/clinchem/39.3.448 ↗
22. Kawai T. · Nat. Immunol. · 2010 · 11 · 37310.1038/ni.1863 ↗
23. Douglas S. M. · Nucleic Acids Res. · 2009 · 37 · 500110.1093/nar/gkp436 ↗
24. Mathieu F. · Nano Lett. · 2005 · 5 · 66110.1021/nl050084f ↗
25. Douglas S. M. · Proc. Natl. Acad. Sci. U.S.A. · 2007 · 104 · 664410.1073/pnas.0700930104 ↗
26. Lin C. · Nucleic Acids Res. · 2013 · 41 · e4010.1093/nar/gks1070 ↗
27. Chan Y. H. · Proc. Natl. Acad. Sci. U.S.A. · 2009 · 106 · 97910.1073/pnas.0812356106 ↗
28. Ollivon M. · Biochim. Biophys. Acta, Biomembr. · 2000 · 1508 · 3410.1016/S0304-4157(00)00006-X ↗
29. Noda T. · Front. Virol. · 2012 · 2 · 269
30. Soo Choi H. · Nat. Biotechnol. · 2007 · 25 · 116510.1038/nbt1340 ↗
31. Mei Q. · Nano Lett. · 2011 · 11 · 147710.1021/nl1040836 ↗
32. Surana S. · Methods · 2013 · 64 · 9410.1016/j.ymeth.2013.04.002 ↗
33. Lee H. · Nat. Nanotechnol. · 2012 · 7 · 38910.1038/nnano.2012.73 ↗
34. Liu H. · Angew. Chem., Int. Ed. · 2007 · 46 · 251510.1002/anie.200604589 ↗
35. Juul S. · ACS Nano · 2013 · 7 · 972410.1021/nn4030543 ↗
36. Banerjee A. · Angew. Chem., Int. Ed. · 2013 · 52 · 685410.1002/anie.201302759 ↗
37. Karanth H. · J. Pharm. Pharmacol. · 2007 · 59 · 46910.1211/jpp.59.4.0001 ↗
38. Kaliss N. · Exp. Biol. Med. · 1950 · 75 · 1610.3181/00379727-75-18083 ↗